Back

Y-mAbs Therapeutics Quote, Financials, Valuation and Earnings

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly

Buy

YMAB
Y-mAbs Therapeutics

Last Price:

16.49

Seasonality Move:

20.61%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Y-mAbs Therapeutics Price Quote

$16.49

+0.03 (+8.27%)

(Updated: May 2, 2024 at 6:22 AM ET)

Y-mAbs Therapeutics Key Stats

Buy

Y-mAbs Therapeutics (YMAB) is a Buy

Day range:

$15.36 - $17.00

52-week range:

$4.60 - $20.90

Dividend yield:

P/E ratio:

0.00

P/S ratio:

7.98

P/B ratio:

6.72%

Volume:

319.2K

Avg. volume:

324.9K

1-year change:

166.77%

Market cap:

$678.5M

Revenue:

$84.8M

EPS:

$-0.49

How Much Does Y-mAbs Therapeutics Make?

How Much Are Y-mAbs Therapeutics's Sales Annually?
YMAB Revenues are $84.8M
How Much Profit Does Y-mAbs Therapeutics's Make A Year?
YMAB net income is -$21.4M

Is Y-mAbs Therapeutics Growing As A Company?

What Is Y-mAbs Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.26%
What Is Y-mAbs Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Y-mAbs Therapeutics Stock Price Performance

Did Y-mAbs Therapeutics Stock Go Up Last Month?
Y-mAbs Therapeutics share price went up by 1.67% last month
Did YMAB's Share Price Rise Over The Last Year?
YMAB share price rose by 166.77% over the past 1 year

What Is Y-mAbs Therapeutics 52-Week High & Low?

What Is Y-mAbs Therapeutics’s 52-Week High Share Price?
Y-mAbs Therapeutics has traded as high as $20.90 over the past 52 weeks
What Is Y-mAbs Therapeutics’s 52-Week Low Share Price?
Y-mAbs Therapeutics has traded as low as $4.60 over the past 52 weeks

Y-mAbs Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Y-mAbs Therapeutics?

How Much Debt Does Y-mAbs Therapeutics Have?
Total long term debt quarterly is $0
How Much Cash Does Y-mAbs Therapeutics Have?
Cash and short term investments quarterly total is $78.6M
What Is Y-mAbs Therapeutics’s Book Value Per Share?
Book value per share is 2.31

Is Y-mAbs Therapeutics Cash Flow Positive?

What Is YMAB Cash Flow From Operations?
Cash flow from operations (TTM) is -$27.2M
What Is Y-mAbs Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $100K
What Is Y-mAbs Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0

Y-mAbs Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
YMAB return on invested capital is -20.49%
What Is Y-mAbs Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -16.04%
What Is YMAB Return On Equity?
ROE is a measure of profitability and is -20.49%

Y-mAbs Therapeutics Earnings Date & Stock Price

What Is Y-mAbs Therapeutics's Stock Price Today?
A single share of YMAB can be purchased today for 16.46
What Is Y-mAbs Therapeutics’s Stock Symbol?
Y-mAbs Therapeutics trades on the nasdaq under the ticker symbol: YMAB
When Is Y-mAbs Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Y-mAbs Therapeutics is scheduled on May 7, 2024
When Is YMAB's next ex-dividend date?
Y-mAbs Therapeutics's next ex-dividend date is May 2, 2024
How To Buy Y-mAbs Therapeutics Stock?
You can buy Y-mAbs Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Y-mAbs Therapeutics Competitors

Who Are Y-mAbs Therapeutics's Competitors?
Below is a list of companies who compete with Y-mAbs Therapeutics or are related in some way:
- The Cooper Companies Inc (COO)
- Humacyte Inc (HUMA)
- Moderna Inc (MRNA)
- NovaBay Pharmaceuticals Inc (NBY)
- Puma Biotechnology Inc (PBYI)

Y-mAbs Therapeutics Dividend Yield